BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

633 related articles for article (PubMed ID: 2720644)

  • 1. In vivo characterization of combination antitumor chemotherapy with calcium channel blockers and cis-diamminedichloroplatinum(II).
    Onoda JM; Nelson KK; Taylor JD; Honn KV
    Cancer Res; 1989 Jun; 49(11):2844-50. PubMed ID: 2720644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin and nifedipine: synergistic cytotoxicity against murine solid tumors and their metastases.
    Onoda JM; Jacobs JR; Taylor JD; Sloane BF; Honn KV
    Cancer Lett; 1986 Feb; 30(2):181-8. PubMed ID: 3955540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination chemotherapy with cisplatin and nifedipine: synergistic antitumor effects against a cisplatin-resistant subline of the B16 amelanotic melanoma.
    Onoda JM; Nelson KK; Pilarski SM; White NS; Mihu RG; Honn KV
    Clin Exp Metastasis; 1990; 8(1):59-73. PubMed ID: 2293914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics by calcium channel blockers and calmodulin inhibitors].
    Tsuruo T
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):750-9. PubMed ID: 6585181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin and nifedipine: synergistic antitumor effects against an inherently cisplatin-resistant tumor.
    Onoda JM; Nelson KK; Taylor JD; Honn KV
    Cancer Lett; 1988 May; 40(1):39-47. PubMed ID: 3370629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on calcium-channel blocking agents.
    Talbert RL; Bussey HI
    Clin Pharm; 1983; 2(5):403-16. PubMed ID: 6354566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium antagonists. Mechanisms, therapeutic indications and reservations: a review.
    Opie LH
    Q J Med; 1984; 53(209):1-16. PubMed ID: 6324268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous assessment of effects of calmodulin antagonists and Ca++ channel blockers on the electrophysiological and mechanical characteristics in excised guinea-pig papillary muscles.
    Koyama K; Himori N
    Arch Int Pharmacodyn Ther; 1988; 292():141-56. PubMed ID: 3395166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium channel antagonists and the treatment of migraine.
    Greenberg DA
    Clin Neuropharmacol; 1986; 9(4):311-28. PubMed ID: 2425960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium channel blocker treatment of tumor cells induces alterations in the cytoskeleton, mobility of the integrin alpha IIb beta 3 and tumor-cell-induced platelet aggregation.
    Timar J; Chopra H; Rong X; Hatfield JS; Fligiel SE; Onoda JM; Taylor JD; Honn KV
    J Cancer Res Clin Oncol; 1992; 118(6):425-34. PubMed ID: 1377695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium antagonists potentiate P-glycoprotein-independent anticancer drugs in chronic lymphocytic leukemia cells in vitro.
    Vilpo J; Koski T; Vilpo L
    Haematologica; 2000 Aug; 85(8):806-13. PubMed ID: 10942926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium ionophore (A23187)- and arachidonic acid-stimulated prostaglandin release from microvascular endothelial cells: effects of calcium antagonists and calmodulin inhibitors.
    Gerritsen ME; Nganele DM; Rodrigues AM
    J Pharmacol Exp Ther; 1987 Mar; 240(3):837-46. PubMed ID: 3104581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of calcium channel blockers on platelet GPIIb-IIIa as a calcium channel in liposomes: comparison with effects on the intact platelet.
    Rybak ME; Renzulli LA
    Thromb Haemost; 1992 Jan; 67(1):131-6. PubMed ID: 1319614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium-channel blockers and beta blockers: advantages and disadvantages of combination therapy in chronic stable angina pectoris.
    Krikler DM; Harris L; Rowland E
    Am Heart J; 1982 Sep; 104(3):702-8. PubMed ID: 6126115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioprotective effects of calcium antagonists used alone or with other types of radioprotectors.
    Floersheim GL
    Radiat Res; 1993 Jan; 133(1):80-7. PubMed ID: 8434117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the cardiac and vasodilatory effects of some calcium entry blockers in perfused isolated guinea-pig hearts.
    Boddeke HW; Wilffert B; Heynis JB; van de Haar Keuken V; Jonkman FA; van Zwieten PA
    Arch Int Pharmacodyn Ther; 1987 Aug; 288(2):175-85. PubMed ID: 3675080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of nifedipine, verapamil, diltiazem and trifluoperazine on the antinociceptive activity of acetaminophen.
    Koleva M; Dimova S
    Methods Find Exp Clin Pharmacol; 2000 Dec; 22(10):741-5. PubMed ID: 11346895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol alters the binding of Ca2+ channel blockers to the membrane lipid bilayer.
    Mason RP; Moisey DM; Shajenko L
    Mol Pharmacol; 1992 Feb; 41(2):315-21. PubMed ID: 1531693
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 32.